TUPELO — High blood pressure, or hypertension, is the top preventable cause of strokes and heart attacks in the United States, according to Dr. Barry Bertolet, an interventional cardiologist at the ...
Ultrasound-based renal denervation (Paradise; ReCor Medical) significantly lowers systolic blood pressure when compared with a sham procedure in patients with resistant hypertension treated on a ...
SAN FRANCISCO, CA—Renal denervation continues to make a comeback as a blood pressure-lowering therapy years following the disappointing results of the SYMPLICITY HTN-3 trial, and now new randomized ...
Recent data suggest that peri-arterial renal sympathetic nerve fibers are less dense in distal segments and dorsal locations and that these nerves are primarily composed of efferent rather than ...
Please provide your email address to receive an email when new articles are posted on . Ultrasound renal denervation for patients with triple-therapy resistant hypertension successfully lowered ...
ATLANTA - At 69, Paul Griffin of Newnan has been living with high blood pressure for about 25 years. Diagnosed in his early 40s, Griffin's doctor put him on a drug that, he says, caused some negative ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth interventional cardiologists treated the first patient with a revolutionary new renal denervation (RDN) procedure, now offered for patients with poorly ...
Cardiologists are welcoming the arrival of a new device-based hypertension treatment called renal denervation and asking Medicare to cover the procedure for a large patient population. Doctors, ...
Kidney denervation, a procedure where the nerves in renal arteries are burned, may be a future treatment for people whose blood pressure remains high despite medication use. Results from the ...
I am Eve and I am naked and ashamed. I have eaten the fruit of the tree of renal denervation and I now forage fig leaves to hide my embarrassment. How long I've managed hypertension while ...
September 12, 2012 (Menlo Park, California) – A complex analysis of the SYMPLICITY HTN 2 trial, first presented at the American College of Cardiology 2012 Scientific Sessions, suggests that renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback